Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients

NCT05076812 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05076812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05076812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2021
Completion date
December 31, 2022
Enrollment
96 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis